1Barrio R, Lopez Capape M, Martinez Badas I, et al. Gravesdisease in children and adolescents : response to long - term treatment. Acta Paediatr, 2005, 94 (11): 1583.
2Coca Perez A, Colino Alcol E, Lopez Capape M, et al. Graves'disease in preschool children. An Pediatr (Bare) , 2005, 63 (3) : 259.
4Bartalena L, Tanda ML, Bogazzi F, et al. An upd,lte on the pharmacological management of hyperthyroidism due to Graves disease. Expert Opln Pharmacother, 2005, 6 (6) : 851.
5Chakrabarti B. Radio - iodine ( Na1131 ) therapy in hyperthyroidism. J Indian Med Assoe, 2001, 99 (11): 642.
6Mysliwiec J, Oklota M, Nikolajuk A, et al. The assessment of usefulhess of humoral markers estimation in patients with autoimmune thyroid diseases. Pol Merkuriusz Lek, 2005, 19 (113) : 663.
7Zarkovie M. Autoimmune thyroid disease and brain. Srp Arh Celok Lek, 2005, 133 Suppl 1 (88) : 91.
8Diklic A, Zivaljevic V, Paunovic I, et al. Surgical procedures in patients with thyroid autoimmune disease. Srp Arh Celok Lek, 2005, 133 ( Suppl 1 ) : 77.
9Kurita S, sakurai M, kita Y, et al. Measurement of thyroid blood flow area is useful for diagnosing the cause of thyrotoxicosis. Thyroid, 2005, 15 (11): 1249.
10Beck - Peceoz P, Persani L, LaFranchi S. Safety of medications and hormones used in the treatment of pediatric thyroid disorders. Pediatr Endocrinol Rev, 2004, 2 (Suppl 1) : 124.
二级参考文献7
1Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endcrinol Metab, 1998,11:3766-3776.
2Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patient. J Clin Endcrinol Metab, 2004,89:4229-4233.
3Sarkar SD, Beierwaltes WH, Gill SP, et al. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med, 1976, 17:460-464.
4Safa AM, Schumacher P, Antonio RA. Long-tern follow-up results in children and adolescents with radioactive iodine (131I) for hyperthyroidism. N Engl J Med, 1975,292:167-171.
5Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents. J Pediatr, 1977, 91: 313-320.
6Gruneiro-Papendieck L, Chiesa A, Finkielstain G, et al. Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab. 2003, 16:1249-1255.
5Demirbilek H, Kandemir N, Gone EN,et al. Hashimoto's thyroiditis in children and adolescents:A retrospective study on clinical, epidemiological and laboratory properties of the disease [ J ]. J Pediatr Endocrinol Metab,2007,20 ( 11 ) : 1199 - 1205.
6Marino M, Barbesino G, Pinchera A ,et al. Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis [ J ]. Thyroid,2000,10 (9) :799 - 802.
